Clinical trials
Recruiting Phase 1 Obesity trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
95 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2018 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 10 |
| 2025 | 20 |
| 2026 | 57 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 95 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 20 |
| Eli Lilly and Company | 6 |
| Gan & Lee Pharmaceuticals. | 4 |
| Columbia University | 3 |
| Fujian Shengdi Pharmaceutical Co., Ltd. | 3 |
| Mayo Clinic | 3 |
| Shanghai Minwei Biotechnology Co., Ltd | 3 |
| AstraZeneca | 2 |
| Beijing QL Biopharmaceutical Co.,Ltd | 2 |
| Boehringer Ingelheim | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 95 |
| Overweight | 57 |
| Diabetes Mellitus, Type 2 | 9 |
| Insulin Resistance | 8 |
| Diabetes Mellitus | 4 |
| Hypertension | 4 |
| Diabetes Mellitus, Type 1 | 3 |
| Endometrial Neoplasms | 3 |
| Hyperinsulinism | 3 |
| Prediabetic State | 3 |
Trials
Showing 1 to 25 of 95. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.